OneOme Prepares for Commercial Launch in New State-of-the-Art Facility

Minneapolis, Dec. 21, 2015 /PRNewswire/— OneOme, LLC, a pharmacogenomics company, announced today that it will move its corporate office and clinical laboratory to the Highlight Center in northeast Minneapolis in early 2016. The new location will expand OneOme’s operations with a high-throughput clinical laboratory, a dedicated client service area, and an open-office layout to support the growing organization.

“This fully remodeled space has been designed to optimize the pharmacogenomics workflow and provide efficiency for the client services department to ensure we are well-positioned to serve our clients,” said Chief Operating Officer Paul Owen.

“The state-of-the-art laboratory will provide sufficient space to support our expanded pharmacogenomics platform exclusively developed and licensed with Mayo Clinic,” stated Troy Kopischke, Chief Executive Officer. “The expansion brings us closer to our vision of providing the most comprehensive PGx platform at the point of care.”

Construction of the new space is slated to be completed by March, and OneOme will begin to operate from the new location in early to mid-April. At that time, OneOme’s new address will be:

807 Broadway Street NE, Suite 100
Minneapolis, MN 55413
844-ONEOME-5 (844-663-6635)

About OneOme

OneOme, LLC, helps providers make better treatment decisions when prescribing drugs within their current workflow through genetic testing and clinical decision support. OneOme’s pharmacogenomics (PGx) solution combines a patient’s genetic profile and medical history with a curated clinical database backed by Mayo Clinic’s proprietary knowledge to produce an interactive report that easily integrates into current practices.


OneOme, LLC
Paul Owen
Chief Operating Officer
612-200-1039 x2161